Skip to main content

KTTA- Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp. (KTTA) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. KTTA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

RoleInsiderSharesValue30d
Dir199.7K$113.2K-
CEO73.3K$41.6K-
Dir42.9K$24.3K-
Dir35.8K$20.3K-
Dir33.3K$18.9K-

Activity

Buys and sells only

Transactions

1 filings · page 2
DateInsiderRoleTypeSharesPriceValueChg%3M12MSEC
Aug 17, 2022Shahinian EricMember Of 10% Owner GroupBuy155,773$1.21$188,282.83+10.7%-18.3%-52.4%
← PrevPage 2